ישראל - עברית - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 30 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.

ישראל - עברית - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 60 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.

ישראל - עברית - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 90 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol 2 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol 4 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 30 mg - cinacalcet

ישראל - עברית - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 30 mg - cinacalcet

ישראל - עברית - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 60 mg - cinacalcet